Artivion, Inc. AORT

AORT Company Overview

Artivion, Inc. is a U.S.-based medical technology and cardiac surgery company focused on developing, manufacturing, and commercializing products used in aortic disease treatment, cardiac surgery, and tissue preservation. The company operates primarily within the cardiovascular medical device and implantable biologics industries, serving hospitals, cardiac surgeons, and specialty surgical centers globally. Its principal revenue drivers include aortic stent grafts, surgical sealants, mechanical heart valves, and implantable cardiac and vascular tissues. Artivion positions itself as a specialized provider in complex aortic repair and cardiac surgery markets, with an emphasis on physician-focused innovation and integrated procedural solutions.

The company was founded in 1984 as CryoLife, Inc., initially concentrating on the preservation and distribution of human tissues for cardiac and vascular procedures. Over time, the company expanded into medical devices through internal development and acquisitions, including aortic stent graft technologies and surgical adhesives. In 2022, CryoLife formally rebranded as Artivion, Inc. to reflect its broader focus on advanced cardiovascular therapies and innovation-driven surgical technologies.